Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system

MicroRNAs in platelet production and activation

(2011) L. C. Edelstein et al.   BLOOD

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity

(2011) S. Nagalla et al.   BLOOD

Evaluation of platelet transfusion clinical trials - response to Corash & Sherman

(2011) Jean-Louis H. Kerkhoffs   BRITISH JOURNAL OF HAEMATOLOGY

Evaluation of platelet transfusion clinical trials

(2011) Laurence Corash et al.   BRITISH JOURNAL OF HAEMATOLOGY

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

(2011) Miguel Lozano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Transfection of Human Platelets with Short Interfering RNA

(2011) Wei Hong et al.   CTS-Clinical and Translational Science

Equipoise and the Dilemma of Randomized Clinical Trials

(2011) Franklin G. Miller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes

(2011) Abdimajid Osman et al.   PLATELETS

In reply

(2011) Eleftherios C. Vamvakas   TRANSFUSION

The hemostatic efficacy of platelet components prepared with pathogen inactivation

(2011) Laurence Corash   TRANSFUSION

Regulation of mRNA Translation and Stability by microRNAs

(2010) Marc Robert Fabian et al.   Annual Review of Biochemistry

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

(2010) Jean-Pierre Cazenave et al.   TRANSFUSION

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets

(2010) Eleftherios C. Vamvakas   TRANSFUSION

Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?

(2010) Simon J. Stanworth et al.   TRANSFUSION MEDICINE REVIEWS

Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

(2009) E. C. Vamvakas et al.   BLOOD

VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA

(2009) A. A. KONDKAR et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Existence of a microRNA pathway in anucleate platelets

(2009) Patricia Landry et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use

(2009) Jean Claude Osselaer et al.   TRANSFUSION

COMMENTARY: Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks

(2009) Eleftherios C. Vamvakas   TRANSFUSION

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

(2008) N. M. Heddle et al.   BLOOD

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

(2008) Jean C. Osselaer et al.   TRANSFUSION

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

(2008) J. C. Osselaer et al.   VOX SANGUINIS